UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer

Scientific reports, 2021-11, Vol.11 (1), p.22242-8, Article 22242

2021

Volltextzugriff (PDF)

Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma

Cancer letters, 2017-09, Vol.403, p.296-304

2017

Volltextzugriff (PDF)

Tumor Site-Dependent Transport Properties Determine Nanotherapeutics Delivery and Its Efficacy

Translational oncology, 2019-09, Vol.12 (9), p.1196-1205

2019

Volltextzugriff (PDF)

Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients

Cancers, 2023-03, Vol.15 (5), p.1616

2023

Volltextzugriff (PDF)

Inflammatory breast cancer appearance at presentation is associated with overall survival

Cancer medicine (Malden, MA), 2021-09, Vol.10 (18), p.6261-6272

2021

Volltextzugriff (PDF)

Seed- and Soil-Dependent Differences in Murine Breast Tumor Microenvironments Dictate Anti-PD-L1 IgG Delivery and Therapeutic Efficacy

Pharmaceutics, 2021-04, Vol.13 (4), p.530

2021

Volltextzugriff (PDF)

Clinical Characteristics and Outcome of Bone-Only Metastasis in Inflammatory and Noninflammatory Breast Cancers

Clinical breast cancer, 2015-02, Vol.15 (1), p.37-42

2015

Volltextzugriff (PDF)

A combination of circulating tumor cell (CTC) and cancer stem cell (CSC) markers to predict the prognosis of breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13007-e13007

2023

Volltextzugriff (PDF)

Abstract 2810: Effect of clone dependent difference in the metastatic tumor microenvironment of 4T1 breast cancer on anti-PDL1 antibody delivery & therapeutic efficacy

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2810-2810

2021

Volltextzugriff (PDF)

Abstract PS18-42: Heterogeneous tumor microenvironment in metastatic breast cancer for insufficient anti-PDL1 IgG delivery and its efficacy

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS18-42-PS18-42

2021

Volltextzugriff (PDF)

Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape

Expert opinion on therapeutic targets, 2022-05, Vol.26 (5), p.405-425

2022

Volltextzugriff (PDF)

Abstract 1577: Thrombus formation inside liver metastasis of breast cancer by pegylated liposomal doxorubicin

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1577-1577

2016

Volltextzugriff (PDF)

Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy

Clinical cancer research, 2024-06, Vol.30 (11), p.2424-OF9

2024

Volltextzugriff (PDF)

Abstract PS14-04: A picture worth a thousand words - “classic” inflammatory breast cancer (IBC) appearance associated with overall survival

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS14-04-PS14-04

2021

Volltextzugriff (PDF)

ctDNA detection before and during systemic therapy for inflammatory breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e12523-e12523

2023

Volltextzugriff (PDF)

Biomarker analysis of phase II pembrolizumab maintenance treatment after chemotherapy response in patients with HER2-negative inflammatory breast cancer and triple-negative breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1105-1105

2023

Volltextzugriff (PDF)

Tumor progression effects on drug vector access to tumor-associated capillary bed

Journal of controlled release, 2017-09, Vol.261, p.216-222

2017

Volltextzugriff (PDF)

Abstract 1007: Spatial, temporal and heterogeneous changes in transport phenotype in liver metastasis of breast cancer

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.1007-1007

2022

Volltextzugriff (PDF)

Abstract 3560: Quantified kinematics and wearable sensors to predict serious adverse events in patients undergoing cancer therapy trials

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.3560-3560

2024

Volltextzugriff (PDF)

Abstract 403: Acquired resistance to pegylated liposomal doxorubicin

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.403-403

2015

Volltextzugriff (PDF)

Abstract P1-07-13: Extramedullary hematopoiesis aids initiation of cancer metastasis

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P1-P1-07-13

2015

Volltextzugriff (PDF)

Abstract PO2-09-05: Building genomic and transcriptomic data among African American and Black patients with triple-negative inflammatory breast cancer

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO2-09-05-PO2-09-05

2024

Volltextzugriff (PDF)

Abstract 4852: High brain relapse rates in stage III triple negative inflammatory breast cancer are independent of systemic therapy

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.4852-4852

2024

Volltextzugriff (PDF)

Abstract PO2-03-06: Pathological complete response with chemotherapy and immune checkpoint inhibition in triple negative inflammatory breast cancer (TN-IBC)

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO2-03-06-PO2-03-06

2024

Volltextzugriff (PDF)

Abstract PO2-02-14: Development of a multi-institutional, photograph-rich clinical dataset to test and validate a novel inflammatory breast cancer (IBC) scoring system

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO2-02-14-PO2-02-14

2024

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

Englisch
(140)
Japanisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer

Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma

Tumor Site-Dependent Transport Properties Determine Nanotherapeutics Delivery and Its Efficacy

Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients

Inflammatory breast cancer appearance at presentation is associated with overall survival

Seed- and Soil-Dependent Differences in Murine Breast Tumor Microenvironments Dictate Anti-PD-L1 IgG Delivery and Therapeutic Efficacy

Clinical Characteristics and Outcome of Bone-Only Metastasis in Inflammatory and Noninflammatory Breast Cancers

A combination of circulating tumor cell (CTC) and cancer stem cell (CSC) markers to predict the prognosis of breast cancer

Abstract 2810: Effect of clone dependent difference in the metastatic tumor microenvironment of 4T1 breast cancer on anti-PDL1 antibody delivery & therapeutic efficacy

Abstract PS18-42: Heterogeneous tumor microenvironment in metastatic breast cancer for insufficient anti-PDL1 IgG delivery and its efficacy

Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape

Abstract 1577: Thrombus formation inside liver metastasis of breast cancer by pegylated liposomal doxorubicin

Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy

Abstract PS14-04: A picture worth a thousand words - “classic” inflammatory breast cancer (IBC) appearance associated with overall survival

ctDNA detection before and during systemic therapy for inflammatory breast cancer

Biomarker analysis of phase II pembrolizumab maintenance treatment after chemotherapy response in patients with HER2-negative inflammatory breast cancer and triple-negative breast cancer

Tumor progression effects on drug vector access to tumor-associated capillary bed

Abstract 1007: Spatial, temporal and heterogeneous changes in transport phenotype in liver metastasis of breast cancer

Abstract 3560: Quantified kinematics and wearable sensors to predict serious adverse events in patients undergoing cancer therapy trials

Abstract 403: Acquired resistance to pegylated liposomal doxorubicin

Abstract P1-07-13: Extramedullary hematopoiesis aids initiation of cancer metastasis

Abstract PO2-09-05: Building genomic and transcriptomic data among African American and Black patients with triple-negative inflammatory breast cancer

Abstract 4852: High brain relapse rates in stage III triple negative inflammatory breast cancer are independent of systemic therapy

Abstract PO2-03-06: Pathological complete response with chemotherapy and immune checkpoint inhibition in triple negative inflammatory breast cancer (TN-IBC)

Abstract PO2-02-14: Development of a multi-institutional, photograph-rich clinical dataset to test and validate a novel inflammatory breast cancer (IBC) scoring system

Suchergebnisse filtern